Article

Prescription Drug Spending Spike Highlights AJPB Week in Review

Author(s):

Davy James, Managing Editor

Top articles of the week on The American Journal of Pharmacy Benefits.

Related Videos
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Pharmacy technician working in a pharmacy -- Image credit: sofiko14 | stock.adobe.com
Team of pharmacists -- Image credit: Jacob Lund | stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
Pharmacists working in a pharmacy -- Image credit: Drazen | stock.adobe.com
Related Content
Image Credit: © Africa Studio - stock.adobe.com
October 22nd 2024

Patients With Endometriosis Have an Increased Risk of Developing Cardiovascular Disease

Alexandra Gerlach, Associate Editor
Protecting Against Shingles: Discussing With Your Patients Why Vaccination Matters
October 4th 2024

Protecting Against Shingles: Discussing With Your Patients Why Vaccination Matters

Trisha Winroth, PharmD Ashly McPhillips, PharmD
Image Credit: © freshidea - stock.adobe.com
October 22nd 2024

Controlling Cholesterol: Stroke Prevention and Updated ASA Guidelines

Alexandra Gerlach, Associate Editor
Protecting Against Shingles: Discussing With Your Patients Why Vaccination Matters
October 4th 2024

Protecting Against Shingles: Discussing With Your Patients Why Vaccination Matters

Trisha Winroth, PharmD Ashly McPhillips, PharmD
MiBA and NCOD Partner to Launch Oncology Insights Program: actionable insights and targeted education to enhance data-driven decisions to support better patient care -- Image Credit: © National Community Oncology Dispensing Association (NCODA)
October 22nd 2024

MiBA and NCODA Partner to Launch Oncology Insights Program

Stelara Biosimilar, Selarsdi, Psoriatic Arthritis, Plaque Psoriasis | Image Credit: Diego Cervo - stock.adobe.com
October 22nd 2024

FDA Approves Selarsdi as Biosimlar to Stelara in an Intravenous Formulation

Ashley Gallagher, Associate Editor